<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>05</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of human leukocyte antigen-DRB haplotype in multiple sclerosis population of Khuzestan, Iran</title>
    <FirstPage>154</FirstPage>
    <LastPage>160</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nooshin</FirstName>
        <LastName>Delfan</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Galehdari</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Shafiei</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farideh</FirstName>
        <LastName>Ghanbari-Mardasi</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Tahereh</FirstName>
        <LastName>Latifi</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nastaran</FirstName>
        <LastName>Majdinasab</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Society, School of Rehabilitation, Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Tahereh</FirstName>
        <LastName>Seifi</LastName>
        <affiliation locale="en_US">Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: One of the demyelinating and inflammatory diseases of the central nervous system (CNS) is multiple sclerosis (MS). Though pathogenesis of MS is still unknown, both genetic and environmental factors are involved. The human leukocyte antigen (HLA) class-II alleles including HLA-DRB5*01, DQB1*0602, DRB1*1501, and DQA1*0102 may have remarkable effect in MS risk although it is controversial in studies. As there is no data with respect to the HLA-DRB1*1501-DRB5*01 correlation with MS in Khuzestan Province, Iran, the goal of the survey was to investigate the association of this haplotype with MS in this population.
&#xD;

Methods: The study focused on DRB5*01-DRB1*1501 haplotype association with MS in 200 patients and 200 healthy individuals. Typing of HLA was carried out by polymerase chain reaction (PCR) amplification with sequence-specific primers (SSP) method. SPSS software was used for the statistical analyses.
&#xD;

Results: No association between DRB5*01+-DRB1*1501+ and MS was found (P = 0.156). Distribution of DRB1*1501+-DRB5*01- (carrying DRB1*1501+ but not DRB5*01-) and DRB1*1501--DRB5*01- haplotypes was statistically different between patients and controls (29.73% vs. 11.81%, P &lt; 0.001) and (42.16% vs. 68.50%, P &lt; 0.001), respectively. However, DRB1*1501--DRB5*01+ revealed no association with MS (15.13% vs. 11.81%, P = 0.403). HLA-DRB1*1501--DRB5*01+ was signi&#xFB01;cantly more frequent among female patients with MS (16.19% vs. 6.12%, P = 0.019) and Persian group (17.11% vs. 5.79%, P = 0.027). Positive correlation of HLA-DRB1*1501+-DRB5*01- haplotype with the expanded disability status scale (EDSS) steps from 5 to 10 was observed (62.50% vs. 25.76%, P = 0.026). Moreover, no meaningful association was shown among the haplotypes with EDSS, course of MS, ethnicity, and gender.
&#xD;

Conclusion: Our findings suggest that DRB1*1501+-DRB5*01- and DRB1*1501--DRB5*01- haplotypes may have positive association with MS risk. Also, this survey indicates that HLA-DRB1*1501--DRB5*01+ is involved in susceptibility of the disease among women and Persians. DRB1*1501+-DRB5*01- genotype frequency may have a key role in MS developing.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1464</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Portrayal of a young female in 16th century Islamic art: Does she have anti-NMDAR encephalitis?</title>
    <FirstPage>192</FirstPage>
    <LastPage>194</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Daniel</FirstName>
        <LastName>Kondziella</LastName>
        <affiliation locale="en_US">Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Department of Clinical Medicine, University of Copenhagen, Denmark Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway</affiliation>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Bech</LastName>
        <affiliation locale="en_US">Department of Neurology, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>10</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Portrayal of a young female in 16th century Islamic art: Does she have anti-NMDAR encephalitis?</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1660</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Supratentorial intraparenchymal schwannoma in a 44-year-old woman: A rare case report</title>
    <FirstPage>200</FirstPage>
    <LastPage>202</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Khaleghi</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Arefidoust</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rahele</FirstName>
        <LastName>Yaftian</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Omid</FirstName>
        <LastName>Ghamarnejad</LastName>
        <affiliation locale="en_US">Cerrahpa&#x15F;a Faculty of Medicine, Istanbul University, Istanbul, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Seyyed Mohammad</FirstName>
        <LastName>Ghodsi</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Supratentorial intraparenchymal schwannoma in a 44-year-old woman: A rare case report</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1635</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Human T-lymphotropic virus type I and breastfeeding; systematic review and meta-analysis of the literature</title>
    <FirstPage>174</FirstPage>
    <LastPage>179</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Boostani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ramin</FirstName>
        <LastName>Sadeghi</LastName>
        <affiliation locale="en_US">Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Sabouri</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Washington University, Saint Louis, Missouri, USA</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Ghabeli</LastName>
        <affiliation locale="en_US">Marvdasht Shahid Motahhari Hospital, Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The human T-cell lymphotropic virus type-I (HTLV-I) is the first identified pathogenic human retrovirus. Breastfeeding has been reported to be the predominant route of vertical transmission of HTLV-I. The objective of this systematic review was to pool and evaluate the data on the transmission of HTLV-I with different infant-feeding practices on children born to HTLV-I-positive mothers. We conducted a systematic review of comparison of HTLV-I transmission risk to breastfed and bottle-fed babies.
&#xD;

Methods: We searched the following databases: MEDLINE, SID, Magiran, and Cochrane Library. The search strategy was limited to articles in English. Initial screening identified 254 citations; of these, 96 potentially relevant articles were identified. After reviewing the 96 full-text articles in detail, 7 reports met the inclusion criteria for this review.
&#xD;

Results: Pooled odds ratio (OR) and risk difference (RD) of HTLV-I transmission in the breastfed group compared to the bottle-fed infants were [OR = 3.48, 95% confidence interval (CI): 1.58-7.64, P = 0.0020, Cochran&#x2019;s Q = 27.7, P = 0.0010, and I2 = 67.5%] and (RD = 17.1%, 95% CI: 7.5%-26.7%, P &lt; 0.0001, Cochran&#x2019;s Q = 106, P &lt; 0.0001, and I2 = 91.5%). So, we have evidence to support that exclusive breast feeding more than 6 months in comparison to bottle feeding highly increases transmission rate of HTLV-I infection. We have also enough evidence to support that exclusive breast feeding up to 6 months compared to bottle feeding does not increase transmission rate of HTLV-I infection (pooled OR = 0.912, CI: 0.45-1.80; OR: 3.83, CI: 1.80-8.10, respectively).
&#xD;

Conclusion: The current meta-analysis showed that short period (less than 6 months) of breastfeeding did not increase risk of HTLV-I infection transmission from mother to child among breastfeeders and more than 6 months of breastfeeding significantly increased the risk of HTLV-I infection. However, our meta-analysis shows that refraining from breastfeeding can decrease the risk of vertical HTLV-I transmission.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1614</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">"Eight and a half" and "nine syndrome" rare presentation of pontine lesions; case reports and review of literature</title>
    <FirstPage>189</FirstPage>
    <LastPage>191</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Yadegari</LastName>
        <affiliation locale="en_US">Department of Neuro-Ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Aghsaei-Fard</LastName>
        <affiliation locale="en_US">Department of Neuro-Ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Akbari</LastName>
        <affiliation locale="en_US">Department of Neuro-Ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Mirmohammad-Sadeghi</LastName>
        <affiliation locale="en_US">Department of Neuro-Ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>02</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Eight-and-a-half syndrome (EHS) is one-and-a-half syndrome [(conjugated horizontal gaze palsy and internuclear ophthalmoplegia (INO)] plus ipsilateral fascicular seventh cranial nerve palsy. Involvement of lower pontine tegmentum including the abducens nucleus, the ipsilateral medial longitudinal fasciculus (MLF), and the adjacent facial colliculus contribute to the clinical findings of EHS. Recently, nine syndrome with addition of hemiparesis or hemianesthesia to EHS (due to involvement of adjacent corticospinal tract or medial lemniscus) is suggested.
&#xD;

Methods: Consecutive patients with presentation of EHS or nine syndrome were reviewed from referral neuro-ophthalmology and strabismus clinics.
&#xD;

Results: Three cases of EHS were identified with different etiologies of intracerebral hemorrhage (ICH), demyelination, and neuromyelitis optica spectrum disorder. Moreover, one case of "nine syndrome" due to ICH was described. Brain magnetic resonance imaging (MRI) in all of them revealed lesion in lower tegmentum of pons.
&#xD;

Conclusion: Apart from different etiologies, recognition of EHS or nine syndrome allows precise localization of the lesion to lower pontine tegmentum ipsilaterally.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1510</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence of new-onset migraine in patients with idiopathic intracranial hypertension in comparison to the general population</title>
    <FirstPage>161</FirstPage>
    <LastPage>166</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mansoureh</FirstName>
        <LastName>Togha</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kamran</FirstName>
        <LastName>Shirbache</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Rahmanzadeh</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zeinab</FirstName>
        <LastName>Ghorbani</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran School of Nutritional Sciences and Dietetics, School of Nutrition and Food Technology, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Yari</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Department of Clinical Nutrition and Dietetics, School of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Refaeian</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shirin</FirstName>
        <LastName>Behbahani</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Parsa</FirstName>
        <LastName>Panahi</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Idiopathic intracranial hypertension (IIH) encompasses patients with elevated intracranial pressure (ICP). Generally, it is difficult to make a differential diagnosis between IIH and co-existing migraine headaches. Thus, this article intends to estimate the prevalence of migraine in patients with IIH and explain the occurrence of new-onset migraine after the diagnosis of IIH.
&#xD;

Methods: The case group included 108 patients with IIH referred to the neurology wards of three university hospitals. A random sample of controls (n = 103) were recruited from patients hospitalized in the surgery and orthopedics ward. A checklist for migraine diagnosis was filled out. Cerebrospinal fluid (CSF) pressure and presence or absence of papilloedema (PE) in the patients and any necessary data were also recorded from the inpatient medical documents. All statistical analyses were done by SPSS software.
&#xD;

Results: There were 70 (64.80%) and 22 (21.40%) migraineurs in the case and control groups, respectively, and the difference was found to be significant (P &lt; 0.001). In 26 (37.14%) migraine cases in the IIH group, the disorder was diagnosed after developing IIH. Also, there was a past medical history of having migraine in 44 (62.85%) migraineurs. In the fully adjusted regression models, the odds of being affected by migraine in patients with IIH was 6.17 times greater than the controls [odds ratio (OR) = 7.15, 95% confidence interval (CI) = 3.56-14.36, P &lt; 0.010]. The patients&#x2019; mean CSF opening pressure was 32.10 &#xB1; 1.03 cmH2O and 93 (81.60%) subjects were found to have PE.
&#xD;

Conclusion: It was demonstrated that subjects with IIH might have about a 6-time higher likelihood of developing migraine headache than the general population. These considerations can help prevent misdiagnosis of migraine headache as the recurrence of IIH or uncontrolled IIH and subsequent inappropriate management.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1542</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>16</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Iron chelation in treatment of superficial siderosis</title>
    <FirstPage>195</FirstPage>
    <LastPage>196</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Eda</FirstName>
        <LastName>Derle</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Baskent University, Ankara, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>09</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Iron chelation in treatment of superficial siderosis</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1644</web_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>20</Day>
 </Author>
      <Author>
        <FirstName>Nazanin</FirstName>
        <LastName>Sadraii</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Shiraz Neurosciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Negin</FirstName>
        <LastName>Hadi</LastName>
        <affiliation locale="en_US">Department of Community Medicine, School of Medicine, Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Epilepsy is defined as recurrent unprovoked febrile&#xA0; seizures, which&#xA0; cause&#xA0; disability in patients.&#xA0; This study&#xA0; aims&#xA0; to&#xA0; assess&#xA0; the&#xA0; health-related&#xA0; quality-of-life (QOL) in epileptic patients in Fars Province, southern&#xA0; Iran.
Methods: One-hundred epileptic&#xA0; patients, above 18 years, referred to Shiraz University of Medical Sciences affiliated clinics, were included. The QOL of patients with generalized&#xA0; and&#xA0; partial seizure were assessed using the Iranian valid and&#xA0; reliable&#xA0; Sf-36 questionnaire. Patients&#x2019; socio-demographic and&#xA0; their disease&#xA0; features were also compared&#xA0; with each other using a questionnaire.
Results: In partial epilepsy group (n = 24), the&#xA0; married patients in social functioning (SF) aspect&#xA0; of&#xA0; QOL (64.42 &#xB1; 14.29) (P = 0.024), the&#xA0; patients&#xA0; on antiepileptic drugs&#xA0; (AEDs) monotherapy in both&#xA0; physical functioning (PF) (88.75&#xA0; &#xB1;&#xA0; 11.57)&#xA0; (P =&#xA0; 0.030) and&#xA0; SF (75.00&#xA0; &#xB1;&#xA0; 6.68) (P = 0.022) aspects, the employed patients in PF aspect of QOL ( = 0.023) (91.87 &#xB1; 8.83) and those with high income in mental health aspect of QOL (P = 0.036 and correlation coeDcient = 0.413) got better&#xA0; scores compared&#xA0; with the partial epileptic patients who were single, on polytherapy, unemployed and had low to moderate income. In generalized epilepsy&#xA0; group&#xA0; (n = 76), patients&#xA0; on AEDs monotherapy in PFaspect&#xA0; of QOL (P = 0.025) (78.33 &#xB1; 24.36) and&#xA0; employed&#xA0; patients in vitality aspect (P = 0.023) (57.00 &#xB1; 28.25) had better&#xA0; scores.Data were analyzed using SPSS for windows.
Conclusion: Epilepsy can affect patient&#x2019;s life in a number of ways&#xA0; such as&#xA0; their&#xA0; lives, marriage, occupation, and education. We can encourage patients&#xA0; to find a partner, continue higher education&#xA0; and try to find a job.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/615</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/615/187</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Decompressive craniectomy after unsuccessful intravenous thrombolysis of malignant cerebral infarction.</title>
    <FirstPage>101</FirstPage>
    <LastPage>104</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Humain</FirstName>
        <LastName>Baharvahdat</LastName>
        <affiliation locale="en_US">Department of Neurosurgical, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Etemadrezaie</LastName>
        <affiliation locale="en_US">Department of Neurosurgical, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Zabyhian</LastName>
        <affiliation locale="en_US">Department of Neurosurgical, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Valipour</LastName>
        <affiliation locale="en_US">Neurology Research Group, Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Babak</FirstName>
        <LastName>Ganjeifar</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, School of Medicine, Emdadi Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mohammad</FirstName>
        <LastName>Mousavi Mirzaye</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Payam</FirstName>
        <LastName>Sasannejad</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kavian</FirstName>
        <LastName>Ghandehari</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Intravenous&#xA0; recombinant&#xA0; tissue plasminogen&#xA0; activator&#xA0; (rt-PA) is an approved&#xA0; treatment for acute ischemic stroke within 4.5 h of symptoms onset. Decompressive craniectomy (DC) has been&#xA0; shown&#xA0; as an effective&#xA0; therapeutic&#xA0; modality in malignant&#xA0; middle cerebral&#xA0; artery (MCA) infarction. As rt-PA could result in hemorrhagic&#xA0; complication during or after any surgery DC may be associated with severe bleeding after intravenous thrombolysis.
Case Description: A 57-year-old woman was presented 90 min after the sudden&#xA0; onset of left hemiplegia. Despite intravenous&#xA0; thrombolytic therapy, she lost consciousness within 48 h and brain CT scan showed a right malignant MCA infarction associated&#xA0; with a small bleeding. DC was performed&#xA0; without&#xA0; any complication. The patient improved dramatically.
Conclusion: DC could be done safety for malignant&#xA0; MCA infarction after unsuccessful intravenous thrombolytic therapy&#xA0; even&#xA0; the later was complicated&#xA0; with&#xA0; intra- infarction hemorrhage.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/614</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/614/188</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Fatigue, depression, and physical impairment in multiple sclerosis.</title>
    <FirstPage>105</FirstPage>
    <LastPage>107</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Azimian</LastName>
        <affiliation locale="en_US">Department of Clinical Sciences, School of Medicine, Tehran University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Shahvarughi-Farahani</LastName>
        <affiliation locale="en_US">Department of Clinical Sciences, School of Medicine, Tehran University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Rahgozar</LastName>
        <affiliation locale="en_US">Department of Clinical Sciences, School of Medicine, Tehran University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Nasr</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran ; Department of Medical Sciences, School of Medicine, Medical Students' Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Fatigue, depression, and physical impairment are common&#xA0; among&#xA0; multiple&#xA0; sclerosis (MS) patients. The aim&#xA0; of&#xA0; this&#xA0; study was to&#xA0; determine&#xA0; the&#xA0;&#xA0; relationship between depression,&#xA0; physical impairment,&#xA0; and&#xA0; fatigue&#xA0; in an Iranian MS cohort.
Methods: Fifty consecutive&#xA0; relapsing-remitting MS patients and&#xA0; 50 age- and&#xA0; sex-matched healthy&#xA0; controls (HCs) were recruited&#xA0; from Sina Rehabilitation Clinic,Tehran, ran. The depression&#xA0; substance of Hospital Anxiety and&#xA0; Depression Scal